ALS
Australia based testing services provider.
Launch date
Employees
Market cap
$4.7b
Enterprise valuation
$5.7b (Public information from Sep 2024)
Share price
AUD13.945 ALQ.AX
Brisbane Queensland (HQ)
Financials
Estimates*
| AUD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.8b | 1.8b | 2.1b | 2.3b | 2.5b | 4.5b | 4.9b |
| % growth | - | (4 %) | 20 % | 8 % | 8 % | 85 % | 7 % |
| EBITDA | 414m | 421m | 463m | 587m | 359m | - | - |
| % EBITDA margin | 23 % | 24 % | 22 % | 26 % | 15 % | - | - |
| Profit | 128m | 173m | 191m | 291m | 12.9m | - | - |
| % profit margin | 7 % | 10 % | 9 % | 13 % | 1 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | Post IPO Equity | |
| Total Funding | - | ||
Related Content
Recent News about ALS
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by ALS
Edit
ACQUISITION by ALS Mar 2024
ACQUISITION by ALS Dec 2022
ACQUISITION by ALS Jul 2013
ACQUISITION by ALS Mar 2024
ACQUISITION by ALS May 2023
ACQUISITION by ALS Mar 2024
ACQUISITION by ALS Sep 2023